R

Revolution Medicines
D

RVMD

56.720
USD
-0.09
(-0.16%)
Market Closed
Volume
43,500
EPS
-3
Div Yield
-
P/E
-16
Market Cap
9,541,403,858
OverviewSignalsIdeasNews
Related Instruments
    A
    ARWR
    -2.890
    (-13.49%)
    18.540 USD
    B
    BGNE
    -4.220
    (-2.18%)
    189.320 USD
    C
    CRSP
    0.360
    (0.77%)
    47.280 USD
    E
    EDIT
    -0.11500
    (-4.14%)
    2.66500 USD
    I
    IONS
    -2.970
    (-7.97%)
    34.290 USD
    N
    NTLA
    -1.165
    (-7.71%)
    13.955 USD
    R
    RARE
    -2.865
    (-6.02%)
    44.745 USD
    R
    RGEN
    -17.400
    (-12.22%)
    124.960 USD
    S
    SGMO
    -0.10000
    (-4.67%)
    2.04000 USD
    More
News

Title: Revolution Medicines

Sector: Healthcare
Industry: Biotechnology
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.